Literature DB >> 27369082

Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD).

Jia Wang1, James Sinnett-Smith2, Jan V Stevens1, Steven H Young3, Enrique Rozengurt4.   

Abstract

We examined the regulation of Yes-associated protein (YAP) localization, phosphorylation, and transcriptional activity in intestinal epithelial cells. Our results show that stimulation of intestinal epithelial IEC-18 cells with the G protein-coupled receptor (GPCR) agonist angiotensin II, a potent mitogen for these cells, induced rapid translocation of YAP from the nucleus to the cytoplasm (within 15 min) and a concomitant increase in YAP phosphorylation at Ser(127) and Ser(397) Angiotensin II elicited YAP phosphorylation and cytoplasmic accumulation in a dose-dependent manner (ED50 = 0.3 nm). Similar YAP responses were provoked by stimulation with vasopressin or serum. Treatment of the cells with the protein kinase D (PKD) family inhibitors CRT0066101 and kb NB 142-70 prevented the increase in YAP phosphorylation on Ser(127) and Ser(397) via Lats2, YAP cytoplasmic accumulation, and increase in the mRNA levels of YAP/TEAD-regulated genes (Ctgf and Areg). Furthermore, siRNA-mediated knockdown of PKD1, PKD2, and PKD3 markedly attenuated YAP nuclear-cytoplasmic shuttling, phosphorylation at Ser(127), and induction of Ctgf and Areg expression in response to GPCR activation. These results identify a novel role for the PKD family in the control of biphasic localization, phosphorylation, and transcriptional activity of YAP in intestinal epithelial cells. In turn, YAP and TAZ are necessary for the stimulation of the proliferative response of intestinal epithelial cells to GPCR agonists that act via PKD. The discovery of interaction between YAP and PKD pathways identifies a novel cross-talk in signal transduction and demonstrates, for the first time, that the PKDs feed into the YAP pathway.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein-coupled receptor (GPCR); angiotensin II; protein kinase C (PKC); protein kinase D (PKD); yes-associated protein (YAP)

Mesh:

Substances:

Year:  2016        PMID: 27369082      PMCID: PMC5016186          DOI: 10.1074/jbc.M115.711275

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Comprehensive analysis of kinase inhibitor selectivity.

Authors:  Mindy I Davis; Jeremy P Hunt; Sanna Herrgard; Pietro Ciceri; Lisa M Wodicka; Gabriel Pallares; Michael Hocker; Daniel K Treiber; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2011-10-30       Impact factor: 54.908

2.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers.

Authors:  Javier Muñoz; Daniel E Stange; Arnout G Schepers; Marc van de Wetering; Bon-Kyoung Koo; Shalev Itzkovitz; Richard Volckmann; Kevin S Kung; Jan Koster; Sorina Radulescu; Kevin Myant; Rogier Versteeg; Owen J Sansom; Johan H van Es; Nick Barker; Alexander van Oudenaarden; Shabaz Mohammed; Albert J R Heck; Hans Clevers
Journal:  EMBO J       Date:  2012-06-12       Impact factor: 11.598

3.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

Authors:  B Wolff; J J Sanglier; Y Wang
Journal:  Chem Biol       Date:  1997-02

4.  PKCu is a novel, atypical member of the protein kinase C family.

Authors:  F J Johannes; J Prestle; S Eis; P Oberhagemann; K Pfizenmaier
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

5.  Activation of protein kinase D3 by signaling through Rac and the alpha subunits of the heterotrimeric G proteins G12 and G13.

Authors:  Jingzhen Yuan; Osvaldo Rey; Enrique Rozengurt
Journal:  Cell Signal       Date:  2005-09-28       Impact factor: 4.315

Review 6.  Gastrin, CCK, signaling, and cancer.

Authors:  E Rozengurt; J H Walsh
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

7.  Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway.

Authors:  Donghwa Kim; Shaokun Shu; Marc D Coppola; Satoshi Kaneko; Zeng-Qiang Yuan; Jin Q Cheng
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

8.  Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling.

Authors:  James Sinnett-Smith; Yang Ni; Jia Wang; Ming Ming; Steven H Young; Enrique Rozengurt
Journal:  Am J Physiol Cell Physiol       Date:  2014-03-19       Impact factor: 4.249

9.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Authors:  Toshiro Moroishi; Hyun Woo Park; Baodong Qin; Qian Chen; Zhipeng Meng; Steven W Plouffe; Koji Taniguchi; Fa-Xing Yu; Michael Karin; Duojia Pan; Kun-Liang Guan
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

10.  Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade.

Authors:  Yonggang Zheng; Wei Wang; Bo Liu; Hua Deng; Eliza Uster; Duojia Pan
Journal:  Dev Cell       Date:  2015-09-10       Impact factor: 12.270

View more
  22 in total

1.  Protein kinase D1 (PKD1) phosphorylation on Ser203 by type I p21-activated kinase (PAK) regulates PKD1 localization.

Authors:  Jen-Kuan Chang; Yang Ni; Liang Han; James Sinnett-Smith; Rodrigo Jacamo; Osvaldo Rey; Steven H Young; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

2.  Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.

Authors:  Fang Hao; Qinhong Xu; Yinglan Zhao; Jan V Stevens; Steven H Young; James Sinnett-Smith; Enrique Rozengurt
Journal:  Mol Cancer Res       Date:  2017-03-30       Impact factor: 5.852

3.  Yes-associated protein mediates angiotensin II-induced vascular smooth muscle cell phenotypic modulation and hypertensive vascular remodelling.

Authors:  Maohuan Lin; Woliang Yuan; Zizhuo Su; Caina Lin; Tucheng Huang; Yangxin Chen; Jingfeng Wang
Journal:  Cell Prolif       Date:  2018-08-29       Impact factor: 6.831

4.  Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.

Authors:  Jiyuan Chen; Marisela Rodriguez; Jinrui Miao; Jing Liao; Pritesh P Jain; Manjia Zhao; Tengteng Zhao; Aleksandra Babicheva; Ziyi Wang; Sophia Parmisano; Ryan Powers; Moreen Matti; Cole Paquin; Zahra Soroureddin; John Y-J Shyy; Patricia A Thistlethwaite; Ayako Makino; Jian Wang; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-03-23       Impact factor: 6.011

Review 5.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

6.  The GEF-H1/PKD3 signaling pathway promotes the maintenance of triple-negative breast cancer stem cells.

Authors:  Wolfgang S Lieb; Cristiana Lungu; Raluca Tamas; Hannah Berreth; Philipp Rathert; Peter Storz; Monilola A Olayioye; Angelika Hausser
Journal:  Int J Cancer       Date:  2019-12-14       Impact factor: 7.396

Review 7.  YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.

Authors:  Frank Szulzewsky; Eric C Holland; Valeri Vasioukhin
Journal:  Dev Biol       Date:  2021-01-08       Impact factor: 3.148

8.  12-O-Tetradecanoylphorbol-13-acetate (TPA) is anti-tumorigenic in liver cancer cells via inhibiting YAP through AMOT.

Authors:  Guoqing Zhu; Yan Chen; Xiao Zhang; Qi Wu; Yinghui Zhao; Yuxin Chen; Fenyong Sun; Yongxia Qiao; Jiayi Wang
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

9.  Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival.

Authors:  Enrique Rozengurt; James Sinnett-Smith; Guido Eibl
Journal:  Signal Transduct Target Ther       Date:  2018-04-20

10.  MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.

Authors:  Wenbin Liu; Yongsheng Huang; Dandan Wang; Fei Han; Hongqiang Chen; Jianping Chen; Xiao Jiang; Jia Cao; Jinyi Liu
Journal:  Oncogene       Date:  2021-06-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.